![](/img/cover-not-exists.png)
P679 Development of a novel auto-injector of subcutaneous CT-P13 infliximab: Phase I randomised, open-label, single-dose trial to compare the pharmacokinetics and safety to pre-filled syringe in healthy subjects
Schreiber, S, Ben-Horin, S, Ye, B D, Westhovens, R, Yoo, D H, Lee, S J, Suh, J H, Byeon, J H, Reinisch, WVolume:
13
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjy222.803
Date:
January, 2019
File:
PDF, 1.30 MB
english, 2019